Abbott will support Mylan's bid for Perrigo

25 June 2015 - Deborah Wilkes

Archived

Abbott has confirmed its support for Mylan's standalone strategy, and plans to use its 14.5% stake in Mylan to back the generics company's hostile takeover bid for Perrigo. Meanwhile, Teva continues to pursue its hostile takeover of Mylan, and has increased its stake in the company to 4.61%.

Click tags below for more information on topics:

Mylan

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: